Published in J Pharm Biomed Anal on November 19, 2008
Bioactivity determination of native and variant forms of therapeutic interferons. J Biomed Biotechnol (2011) 0.92
Use of a standardized MxA protein measurement-based assay for validation of assays for the assessment of neutralizing antibodies against interferon-β. J Interferon Cytokine Res (2013) 0.76
Identifying predictors of high quality care in English general practice: observational study. BMJ (2001) 9.34
The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res (1986) 4.16
Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages. Clin Exp Immunol (1989) 3.09
Measuring safety climate in health care. Qual Saf Health Care (2006) 2.90
Mutant cells that do not respond to interleukin-1 (IL-1) reveal a novel role for IL-1 receptor-associated kinase. Mol Cell Biol (1999) 2.77
Geriatric care in general practice. A medicosocial survey of 391 patients undertaken by health visitors. J R Coll Gen Pract (1969) 2.65
Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet (1989) 2.43
Reconstitution of interleukin 2 with albumin for infusion. Lancet (1990) 2.37
Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Invest (1991) 2.37
Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection. J Clin Invest (1998) 2.30
Epidemiology of incident spinal fracture in a complete population. Spine (Phila Pa 1976) (1996) 2.12
Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production. J Clin Invest (1989) 2.01
Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon. Clin Exp Immunol (1988) 1.92
Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus. Lancet (1987) 1.91
Cytokine inter-relationships and their association with disease activity in arthritis. Br J Rheumatol (1992) 1.85
Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet (1988) 1.82
238U/235U variations in meteorites: extant 247Cm and implications for Pb-Pb dating. Science (2009) 1.70
Association of innate immune activation with latent Epstein-Barr virus in active MS lesions. Neurology (2011) 1.70
Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity. J Exp Med (1989) 1.68
Preparation and characterization of monoclonal antibodies directed against antigenic determinants of recombinant human tumour necrosis factor (rTNF). Hybridoma (1987) 1.68
Antitumor activity of the novel human breast cancer growth inhibitor, mammary-derived growth inhibitor-related gene, MRG. Cancer Res (1997) 1.66
Lipopolysaccharide, tumor necrosis factor, and interleukin-1 interact to cause hypotension. J Lab Clin Med (1992) 1.65
Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4+ effector memory T-cells. Br J Pharmacol (2010) 1.65
Immune interferon produced to high levels by antigenic stimulation of human lymphocytes with influenza virus. J Exp Med (1981) 1.64
Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production. J Neuroimmunol (1991) 1.63
High levels of interferon alpha in the sera of children with dengue virus infection. Am J Trop Med Hyg (1993) 1.56
Activation of human peripheral blood T lymphocytes by pharmacological induction of protein-tyrosine phosphorylation. Proc Natl Acad Sci U S A (1992) 1.55
Role of tumor necrosis factor in flavone acetic acid-induced tumor vasculature shutdown. Cancer Res (1990) 1.51
Array-based ELISAs for high-throughput analysis of human cytokines. Biotechniques (2001) 1.48
Human and murine macrophages produce TNF in response to soluble antigens of Plasmodium falciparum. Parasite Immunol (1990) 1.40
Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients. J Exp Med (1988) 1.40
The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant (2008) 1.39
Geriatric care in a welfare home. Ulster Med J (1972) 1.36
Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet (1988) 1.35
Cytokines in skin lesions of psoriasis. Cytokine (1990) 1.34
Tumour necrosis factors (alpha, beta) induced by HIV-1 in peripheral blood mononuclear cells potentiate virus replication. AIDS (1990) 1.30
Virus RNA and protein synthesis in cells infected with different strains of Newcastle disease virus. J Gen Virol (1971) 1.29
Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravis. Clin Exp Immunol (2003) 1.28
Cytokines in proliferative vitreoretinopathy. Eye (Lond) (1991) 1.26
Involvement of a gene on chromosome 9 in human fibroblast interferon production. Nature (1979) 1.26
Induction of interferon alpha and gamma from human lymphocytes by dengue virus-infected cells. J Gen Virol (1986) 1.24
Alveolar macrophages in AIDS patients: increased spontaneous tumour necrosis factor-alpha production in Pneumocystis carinii pneumonia. Clin Exp Immunol (1990) 1.23
Influenza virus-specific T cells lead to early interferon gamma in lungs of infected hosts: development of a sensitive radioimmunoassay. J Gen Virol (1989) 1.23
Spontaneous neutralising antibodies to interferon--alpha and interleukin-12 in thymoma-associated autoimmune disease. Lancet (1997) 1.22
Interferon induction and increased natural killer-cell activity in influenza infections in man. Lancet (1981) 1.21
Clonal analysis of functionally distinct human CD4+ T cell subsets. J Exp Med (1988) 1.21
TR60 and TR80 tumor necrosis factor (TNF)-receptors can independently mediate cytolysis. Lymphokine Cytokine Res (1993) 1.16
Ricin resistance in baby hamster kidney cells. Nature (1975) 1.16
An anatomy of general practice. J R Coll Gen Pract (1969) 1.15
Human interferon alpha and gamma production by lymphocytes during the generation of influenza virus-specific cytotoxic T lymphocytes. J Gen Virol (1986) 1.14
Altered production of tumour necrosis factors alpha and beta and interferon gamma by HIV-infected individuals. Clin Exp Immunol (1991) 1.12
Detection of hybridomas secreting monoclonal antibodies to human gamma interferon using a rapid screening technique and specificity of certain monoclonal antibodies to gamma interferon. J Interferon Res (1984) 1.10
Effect of cyclo-oxygenase inhibitors and modulators of cyclic AMP formation on lipopolysaccharide-induced neutrophil infiltration in mouse lung. Br J Pharmacol (1996) 1.10
Variants of hamster fibroblasts resistant to Ricinus communis toxin (ricin). Biochem J (1976) 1.09
Maintenance of traditional cultural orientation is associated with lower rates of obesity and sedentary behaviours among African migrant children to Australia. Int J Obes (Lond) (2008) 1.09
Increased IL-2, IL-4 and interferon-gamma (IFN-gamma) in steroid-sensitive nephrotic syndrome. Clin Exp Immunol (1995) 1.09
A survey of sexual knowledge and attitudes in Borehamwood. Practitioner (1971) 1.08
Cytokines in sera from insulin-dependent diabetic patients at diagnosis. Clin Exp Immunol (1991) 1.08
Human NK cells constitutively express membrane TNF-alpha (mTNFalpha) and present mTNFalpha-dependent cytotoxic activity. Eur J Immunol (1999) 1.07
The effectiveness of nutrition interventions on dietary outcomes by relative social disadvantage: a systematic review. J Epidemiol Community Health (2008) 1.06
Clonal analysis of cytotoxic T lymphocytes (CTL) against autologous melanoma. Classification based on phenotype, specificity and inhibition by monoclonal antibodies to T cell structures. Cancer Immunol Immunother (1986) 1.06
Production of interferon-gamma and tumour necrosis factor-alpha by human T-cell clones expressing different forms of the gamma delta receptor. Immunology (1990) 1.06
Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes. Diabetologia (2005) 1.06
Effect of 2-deoxy-D-glucose on the cell-surface glycoproteins of hamster fibroblasts,. Eur J Biochem (1977) 1.04
Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1). J Pathol (2007) 1.04
TRANK, a novel cytokine that activates NF-kappa B and c-Jun N-terminal kinase. J Immunol (1998) 1.04
Aicardi-Goutières syndrome displays genetic heterogeneity with one locus (AGS1) on chromosome 3p21. Am J Hum Genet (2000) 1.03
Spontaneous production of tumour necrosis factor alpha and interleukin-1 beta during interferon-alpha treatment of chronic HBV infection. Lancet (1990) 1.02
Detection and measurement of cytokines. Blood Rev (1992) 1.02
In vivo induction of gamma interferon and tumor necrosis factor by interleukin-2 infusion following intensive chemotherapy or autologous marrow transplantation. Blood (1989) 1.01
The public's response to the obesity epidemic in Australia: weight concerns and weight control practices of men and women. Public Health Nutr (2000) 1.01
Production of interferon and tumour necrosis factor by cloned human natural cytotoxic lymphocytes and T cells. Clin Exp Immunol (1987) 1.00
Interactions of KB-cell glycoproteins with an adenovirus capsid protein. Eur J Biochem (1976) 0.98
A comparison of the neutralizing properties of monoclonal and polyclonal antibodies to human interferon alpha. J Gen Virol (1984) 0.97
Passive immunization against tumour necrosis factor-alpha (TNF-alpha) and IL-1 beta protects from LPS enhancing glomerular injury in nephrotoxic nephritis in rats. Clin Exp Immunol (1992) 0.97
The role of tumour necrosis factor-alpha and IL-1 in polymorphonuclear leucocyte and T lymphocyte recruitment to joint inflammation in adjuvant arthritis. Clin Exp Immunol (1994) 0.97
Somatic cell genetics of human interferon production in human-rodent cell hybrids. J Gen Virol (1979) 0.95
T cell activation in vivo by dengue virus infection. J Clin Lab Immunol (1995) 0.95
Adrenal hemangioblastoma in Von Hippel-Lindau disease as a cause of secondary erythrocytosis. Am J Med Sci (1987) 0.95
Applicability of telemedicine for assessing patients with schizophrenia: acceptance and reliability. J Clin Psychiatry (1997) 0.94
Release of cytokines during generation of lymphokine-activated killer (LAK) cells by IL-2. Immunology (1989) 0.94
Activation of the tumor necrosis factor-alpha system in the liver in chronic hepatitis B virus infection. Am J Gastroenterol (1996) 0.94
Neutralizing antibodies to granulocyte-macrophage colony-stimulating factor, interleukin-1alpha and interferon-alpha but not other cytokines in human immunoglobulin preparations. Immunology (2000) 0.93
Studies on the structural basis of the RNA polymerase activity of newcastle disease virus particles. J Gen Virol (1973) 0.93
Hepatoid carcinoma of the ovary--a case report. Eur J Gynaecol Oncol (1998) 0.92
Sensitive and specific immunoradiometric assays for human interleukin-1 alpha. Lymphokine Res (1988) 0.92
IL-2- and IFN gamma-enhanced natural cytotoxic activity: analysis of the role of different lymphoid subsets and implications for activation routes. Cell Immunol (1986) 0.92
Development and initial validation of a brief mental health outcome measure. J Pers Assess (1999) 0.92
Spontaneously occurring neutralizing antibodies against granulocyte-macrophage colony-stimulating factor in patients with autoimmune disease. Immunology (1999) 0.91
Infectious hepatitis in Leicester 1963-6. Br Med J (1967) 0.91
Emergency nurses' perceptions of critical incidents and stress debriefing. J Emerg Nurs (1993) 0.91
Modulation of antibody-mediated glomerular injury in vivo by IL-1ra, soluble IL-1 receptor, and soluble TNF receptor. Kidney Int (1995) 0.90
Transforming growth factor-beta induced by live or ultraviolet-inactivated equid herpes virus type-1 mediates immunosuppression in the horse. Immunology (1997) 0.90
Autologous plasma activates Akt/protein kinase B and enhances basal survival and resistance to DNA damage-induced apoptosis in B-chronic lymphocytic leukaemia cells. Br J Haematol (2001) 0.90
Localization of alpha-interferon in the human feto-placental unit. J Endocrinol (1988) 0.90